ESC 365 - Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012

ESC Premium Access

Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012

Session: Lipoproteins and real life: what the randomized clinical trials do not show us

Topic: Epidemiology, lipids

Speaker: Associate Professor S. Martin (Baltimore, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Associate Professor Seth Shay Martin

Johns Hopkins University of Baltimore, Baltimore (United States of America)

2 presentations

0 follower

4 more presentations in this session

State of the art in lipoproteins: lessons from real life registries

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.

Speaker: Mr G. Berkelmans (Utrecht, NL)

Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study

Speaker: Professor W. Koenig (Munich, DE)

Future direction for research in lipids.

Speaker: Professor E. Bruckert (Paris, FR)

Access the full session

Lipoproteins and real life: what the randomized clinical trials do not show us

Speakers: Associate Professor S. Martin, Professor B. Nordestgaard, Mr G. Berkelmans, Professor W. Koenig, Professor E. Bruckert

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources